EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 3.0

Updated Real-World Outcomes with Brentuximab Vedotin in Chinese Lymphoma Patients: A Multicenter, Retrospective Study

Honghan Qiao iD, Xingchen Liu iD, Huijie Nan iD, Mingzhi Zhang, Yanliang Bai, Keshu Zhou, Xudong Zhang

Drug Design, Development and Therapy · 2026-07 · Volume 20 · 1-13

DOI: 10.2147/dddt.s607574 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Drug Design, Development and Therapy, 2026-07. Verfasst von Honghan Qiao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, People's Republic of China. Hauptthemen laut MEDLINE: Brentuximab Vedotin, Lymphoma, Antineoplastic Agents, Immunological. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brentuximab VedotinLymphomaAntineoplastic Agents, ImmunologicalHumansRetrospective StudiesFemaleMaleChinaMiddle AgedAdultAgedYoung AdultAdolescentTreatment OutcomeEast Asian People

Stichwörter der Autor:innen

brentuximab vedotineffectivenesslymphomareal-world studysafety

Substanzen

Brentuximab VedotinAntineoplastic Agents, Immunological

Autor:innen und Institutionen

  • Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, People's Republic of China.
  • Department of Hematology, Henan Cancer Hospital, Zhengzhou, 450008, People's Republic of China.
  • Department of Hematology, Zhengzhou University People's Hospital and Henan Provincial People's Hospital, Zhengzhou, 450003, People's Republic of China.

ORCID-Profile: Honghan Qiao, Xingchen Liu, Huijie Nan

Zitieren

APA

Qiao, H., Liu, X., Nan, H., Zhang, M., Bai, Y., Zhou, K., & Zhang, X. (2026). Updated Real-World Outcomes with Brentuximab Vedotin in Chinese Lymphoma Patients: A Multicenter, Retrospective Study. Drug Design, Development and Therapy, Volume 20, 1-13. https://doi.org/10.2147/dddt.s607574

Vancouver

Qiao H, Liu X, Nan H, Zhang M, Bai Y, Zhou K, et al. Updated Real-World Outcomes with Brentuximab Vedotin in Chinese Lymphoma Patients: A Multicenter, Retrospective Study. Drug Design, Development and Therapy. 2026;Volume 20:1-13. doi:10.2147/dddt.s607574

BibTeX
@article{Qiao2026,
  author = {Qiao, Honghan and Liu, Xingchen and Nan, Huijie and Zhang, Mingzhi and Bai, Yanliang and Zhou, Keshu and Zhang, Xudong},
  title = {Updated Real-World Outcomes with Brentuximab Vedotin in Chinese Lymphoma Patients: A Multicenter, Retrospective Study},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  volume = {Volume 20},
  pages = {1--13},
  doi = {10.2147/dddt.s607574}
}
Kostenlos starten →